Clinical Trial Update: Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated intravenous exenatide in coronary ICU patients with hyperglycemia and acute coronary syndromes, including myocardial infarction, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndromes
• Hyperglycemia
• Myocardial Infarction

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: Saint Luke's Health System | Conditions: Hyperglycemia, Acute Coronary Syndromes | Phase 4 | Status: COMPLETED | Results posted: 2014-11-20